Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Innovation Launches JLINX To Catalyze Company Formation

This article was originally published in Scrip

Executive Summary

Johnson & Johnson Innovation is expanding its innovation strategy to include a new initiative in Europe that combines venture investment and company incubation. The initiative is called JLINX and it is hoped that it will catalyze scientific innovation and successful company formation by offering start-ups flexible ways to grow and collaborate across the European life science ecosystem.


Related Content

Tech Transfer Roundup: J&J Innovation’s Agnostic Approach To Academic Collaboration
Finding Cutting-Edge Science Takes A Broad Net, J&J Innovation’s Urban Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts